New diagnostic tool for complex cancer cases

September 7, 2018, University of Gothenburg
Cancer cell during cell division. Credit: National Institutes of Health

A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.

"We believe that the analytical methods described have rather direct implications that can help patients who lack a correct diagnosis of cancer," says Jonas Nilsson, professor of experimental cancer surgery and director of the Sahlgrenska Cancer Center.

The patient came to Sahlgrenska University Hospital with lung cancer that had recurred several times, despite various treatments in the hospital. The disease proved fatal, but the patient contributed several biopsies for research before dying. The key to a correct diagnosis in this case turned out to be ascertaining and defining the tumor's character and origin in detail, which did not correlate with the clinical picture. This required a large number of analyses before and after the patient's death.

The extensive analytical work presented many surprises. One was a rapid growth of the tumor under the skin of mice when a biopsy was introduced. Another analysis showed that this did not involve a traditional type of lung cancer, but rather a neuroendocrine (hormone-producing) cancer. The tumor also proved to have an unexpected mutation in a specific cancer gene called BRAF.

"What is most remarkable about this finding was that it meant the patient could be treated with what are called BRAF inhibitors, which were effective and also led to a shrinkage of the patient's tumor," Jonas Nilsson says. "The patient's tumor in the mouse also grew more slowly when the mouse was treated with BRAF inhibitors. But unfortunately, the tumor recurred after half a year, and the patient died."

A novel method called mutation signature analysis showed that the tumor most likely originated in the patient's skin. Joakim Karlsson, a doctoral student in bioinformatics and one of three lead authors explains: "When ultraviolet rays from the sun strike skin cells, a very characteristic mutational pattern occurs with the repair of ultraviolet-induced DNA damage. All biopsies from the patient we analyzed had this pattern," he says.

A comparison with the RNA sequencing data from 9,000 tumors in the Cancer Genome Atlas (TCGA) database showed that biopsies from the lung cancer had a correlation to malignant melanoma of more than 90 percent. Therefore, this was not a but a metastasis of melanoma residing in the lung. The value of applying multiple advanced analyses to more complicated tumors to provide proper treatment is underscored by Joakim and the other two lead authors, Roger Olofsson Bagge, a surgeon, and Akif Demir, a pathologist, at Sahlgrenska University Hospital.

Many treatments are approved by the Medical Products Agency Sweden for a certain diagnosis, but not for other. Correction of a diagnosis can therefore result in a different and more appropriate treatment for the patient with complex .

Explore further: Targeting gene mutations to treat ovarian cancers

More information: Roger Olofsson Bagge et al. Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary, JCO Precision Oncology (2018). DOI: 10.1200/PO.18.00002

Related Stories

Targeting gene mutations to treat ovarian cancers

July 30, 2018
New research has shown that ovarian cancer patients with a tumour mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.

The first epigenetic test to diagnose tumors of unknown origin

August 26, 2016
In patients with cancer, initial diagnosis most often includes the detection of the primary or original tumor and the presence or absence of metastases, ie cells from the original tumor that have escaped from their original ...

Improved accuracy for cancer drug testing

June 14, 2017
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg. The method paves the way to much earlier assessment of who benefits from a specific drug and ...

Possible new combination treatment for cancer

June 19, 2014
Scientists at the Sahlgrenska Academy have developed a new cancer treatment that has proved to be effective in mice. The treatment, which is presented in the prestigious scientific journal PNAS, is based on newly discovered ...

New tool mines whole-exome sequencing data to match cancer with best drug

March 29, 2016
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association (JAMIA) describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches ...

Simple blood tests can help detect, target cancer: study

June 4, 2016
Blood samples can be just as effective as invasive tissue biopsies in monitoring cancer and can help doctors better prescribe treatment, a study revealed Saturday.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.